Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
Methods of fabricating semiconductor device
Taxi cab key chain
Position and orientation measurement apparatus, position and orientation measurement method, and storage medium
Biphotonic photosensitizers, nanoparticles containing the same and their use as drugs
Secure mobile ad hoc network
Methods and apparatus to perform time zone determination by a mobile station
Solid-state imaging device and electronic apparatus with antireflection structure
  Randomly Featured Patents
Motion adaptive luminance signal/chrominance signal separation filter
Wound care dressing and method using same
Achieving accurate time-of-flight calibrations with a stationary coincidence point source
Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
Thickness detecting caliper for sheet material having elastic arms with printed coils
Dispersion preparation
Centralized adaptive network memory engine
Method of controlling impurity doping and impurity doping apparatus
Film cartridge loading apparatus for camera
Camera having a shutter instrumentation device which detects the travel of the shutter